Piles and more... dealing with incompetent veins by Micallef, Adrian
The day that man took his first steps on his two hind legs is considered 
a milestone in the evolutionary 
dominance of mankind. Yet this feat 
has borne with it one huge burden – 
the human being is just about the only 
species to suffer from varicose veins 
and haemorrhoids, the visible effects of 
venous insufficiency. 
Chronic venous disease (CVD) has 
been described as ‘an abnormally 
functioning venous system caused 
by venous valvular incompetence 
with or without associated venous 
outflow obstruction, which may 
affect the superficial venous system, 
the deep venous system, or both’.1 
With the minor inclusion of post-
thrombotic syndrome, the majority 
of CVD can be attributed to chronic 
venous insufficiency (CVI) which is the 
pathophysiological mechanism for both 
abnormal leg veins and haemorrhoids. 
Leg veins
The primary pathology here is 
incompetence of the supporting 
valves within the deep and superficial 
venous systems as well as the 
perforating veins connecting these 
two systems,2,3 leading to backflow 
and clinical sequelae. Valve defects 
may have a genetic component, and 
a family history of CVD is a strong risk 
factor for developing features of this 
condition. However, external factors 
definitely play a part in the onset and 
severity of the clinical expression. 
A sedentary lifestyle, prolonged 
standing and wearing of high heels all 
interfere with the calf muscle pump 
which is indispensible for efficient 
venous return. Obesity and pregnancy 
interfere with venous return and 
increase back pressure. There is also 
hormonal influence, which contributes 
to the increased prevalence of venous 
problems in women especially in 
multiparae and those on hormone 
treatment. Hot environments, cardiac 
insufficiency and, of course, age are 
other risk factors for developing CVI. 
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Figure 1: Initial signs of chronic venous insufficiency
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Clinical features vary 
with the severity of 
CVI: in general, the 
more proximal the 
valve failure, the more 
severe the effects
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Figure 2: Comparison of different therapeutic approaches to chronic venous insufficiency
Clinical features vary with the 
severity of CVI: in general, the more 
proximal the valve failure, the more 
severe the effects. Symptoms include 
leg heaviness or pain and night-
time cramps, worsened with heat 
and immobility and improving with 
activity and elevation. The signs of 
CVI start initially with the appearance 
of superficial terminal tributaries 
such as telangiectasis and reticular 
veins progressing through to varicose 
veins, oedema, varicose eczema and 
pigmentation, and ultimately to the 
appearance of ulceration. 
Haemorrhoids
Haemmorhoids can be considered 
as the local (anal) expression of CVI, 
with varicosities of the rectal venous 
plexus being initially asymptomatic but 
eventually progressing to discomfort, 
itching, bleeding and eventually acute 
inflammation and thrombosis. Apart 
from the general lifestyle risk factors 
described for leg veins, additional 
local risks factors include change in 
bowel habits, prolonged coughing or 
sneezing, rectal pathology and local 
trauma (including intercourse). 
Management of CVI
The therapeutic objectives 
of treating CVI in leg veins and 
haemorrhoids are threefold: (1) 
immediate clinical improvement; (2) 
prevention of evolution of venous 
disease; and (3) prevention of 
complications such as post-thrombotic 
syndrome. Unsightly spider and 
reticular veins are often a reason 
for referral for cosmetic removal 
although they may be symptomatic, 
and can be treated with procedures 
like sclerotherapy4 and laser ablation. 
Sclerotherapy5 and endovenous 
ablation with laser or radiofrequency6 
are also effective minimally invasive 
treatments for minor varicosities, but 
for advanced disease surgery, vein 
ligation or stripping is often necessary. 
Haemorrhoids may also be managed 
conservatively initially with topical 
treatment but eventually require 
interventions such as sclerotherapy, 
excision or rubber band ligation. 
Phlebotonics (venotonics) 
are a class of recently developed 
compounds, mostly plant-derived, 
which have been clinically proven to 
have a corrective effect on CVI by 
improving venous tone, decreasing 
capillary permeability, increasing 
lymphatic drainage, and reducing 
release of inflammatory mediators 
by inhibiting migration and activation 
of leucocytes.7 Diosmin is a well 
studied venotonic in both leg vein 
insufficiency8 and haemorrhoids;9 it 
is a natural flavonoid and comes in 
either micronized or coaggregated 
(600mg) forms; the latter allows for a 
more convenient dosage regimen for 
the conditions indicated. This is due to 
the coaggregation of diosmin, which 
increases residence time of the active 
principle in the organism, because of 
its entry in the enterohepatic cycle.
Of course, improving general 
lifestyle measures are central to 
the long-term success of these 
interventions. Weight loss, a more 
active lifestyle, wearing correct 
footwear (maximum of 3-4cm heels), 
a high-fibre diet, avoidance of hot 
environment, as well as wearing 
of support garments and avoiding 
constrictive clothing are all factors 
which should be highlighted in 
the family doctor’s surgery when 
managing this medically important 
condition.  
Infectious hepatitis and HIV constitute 
a major global health risk. At the 
moment it is estimated that 350 
million people are infected chronically 
with Hepatitis B (HBV), around 170 
million people are chronically infected 
with Hepatitis C (HCV) and 33.3 
million are living with HIV.  Malta, 
through the Health Promotion and 
Disease Prevention Directorate, has 
joined an EU-funded project targeting 
these three infectious diseases. This 
project, named H-CUBE, aims to 
provide a strong basis for monitoring 
health determinants in STDs 
spreading. The general objectives 
of the project are to identify and 
disseminate good practices, contents 
and tools about Hepatitis B, Hepatitis 
Prevention of Hepatitis b, C 
and HIV... H-CUbE project
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C and HIV training programmes and 
prevention campaigns. The aim is to 
help Public Administrations and NGOs 
in the EU, particularly in Italy, Romania, 
Greece, Slovenia, Poland, Czech 
Republic, Bulgaria, Hungary, Cyprus, 
Malta and Lithuania. 
All information gathered is being used 
to organise, targeted training courses for 
health care personnel directly involved 
in the prevention, treatment and support 
services. Malta at present is conducting 
e-learning courses for healthcare workers 
and counsellors. Another target group 
is parents. This course will help parents 
become more aware on these specific 
infectious diseases issues and to be 
able to give detailed information to their 
children. 
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Additionally, prevention campaigns 
in many meeting venues for young 
people, the population most at risk 
of infection, will be organised in the 
participating countries. In Malta these 
were launched on the occasion of the 
first official WHO World Hepatitis Day 
on the 28th of July and will be ongoing 
throughout summer. This project is very 
useful for Malta. These three disease 
have been identified as priority diseases 
in an exercise done to identify priority 
infectious diseases in Malta and ties in 
well with the sexual health policy which 
the Ministry for Health, the Elderly and 
Community Care is fully committed to 
implement. More information on the 
project can be found at http://www.
hcube-project.eu.  
The signs of CVI start initially with the 
appearance of superficial terminal tributaries 
such as telangiectasis and reticular veins 
progressing through to varicose veins, oedema, 
varicose eczema and pigmentation, and 
ultimately to the appearance of ulceration
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